The Weight Loss Showdown: Semaglutide vs. Tirzepatide Head-to-Head Study!

PRESENTER: Nawras Silin, MD

Internal Medicine Resident, PGY-3

Mentor: Russell Fung, MD

Learning Objectives

• Compare the effectiveness of tirzepatide vs. semaglutide on weight loss.
• Evaluate the safety profiles of semaglutide and tirzepatide, focusing on the incidence of gastrointestinal adverse events.
• Interpret study limitations and their implications on findings for clinical practice.
• Apply the study findings to clinical practice while considering the patient’s comorbidities.

Intended Audience: Physicians, Clinical Staff

Physician credits awarded. Lunch will be served.